Literature DB >> 31302790

Different risks of nodal metastasis by tumor location in remnant gastric cancer after curative gastrectomy for gastric cancer.

Kazuya Takahashi1, Takaki Yoshikawa2, Shinji Morita1, Takahiro Kinoshita3, Masahiro Yura1, Sho Otsuki1, Masanori Tokunaga3, Yukinori Yamagata1, Akio Kaito3, Hitoshi Katai1.   

Abstract

BACKGROUND: Curative surgery for remnant gastric cancer (RGC) after gastrectomy for gastric cancer (GC) can be challenging. We examined the risk factors for lymph node metastasis in RGC, especially for tumors located at the greater curvature (G) or non-greater curvature (NG), to determine the appropriate indications of curative surgery.
METHODS: Data from the two high-volume centers of Japan between 1998 and 2018 were retrospectively reviewed. Among the 137 patients enrolled in this study, 34 were classified as the G group and 103 as the NG group. The incidence of lymph node metastasis and its risk factors was evaluated.
RESULTS: Lymph node metastasis was observed in 21.2% (29/137), including 38.2% (13/34) in the G group and 15.5% (16/103) in the NG group (p = 0.008). A logistic regression analysis showed that tumor location of G or NG (p = 0.042), tumor size (p = 0.002) and depth of invasion (p = 0.009) were significant independent risk factors for nodal metastasis. Risk classification using these factors showed that clinical T1-T2 with a maximum size < 35 mm located at the non-greater curvature had the lowest nodal metastatic risk (4.3%).
CONCLUSIONS: Tumor location at the G or NG was a significant risk factor for nodal metastasis in RGC. When selecting curative surgery for RGC, physicians should consider the nodal metastatic risk calculated by the tumor location, size and depth of invasion.

Entities:  

Keywords:  Initial gastrectomy for gastric cancer; Nodal metastasis; Remnant gastric cancer

Mesh:

Year:  2019        PMID: 31302790     DOI: 10.1007/s10120-019-00989-x

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  16 in total

1.  Gastric remnant carcinoma: just another proximal gastric cancer or a unique entity?

Authors:  E Newman; M F Brennan; S N Hochwald; L E Harrison; M S Karpeh
Journal:  Am J Surg       Date:  1997-04       Impact factor: 2.565

2.  Significance of lymphadenectomy with splenectomy in radical surgery for advanced (pT3/pT4) remnant gastric cancer.

Authors:  Hiroki Sugita; Eri Oda; Masahiko Hirota; Shinji Ishikawa; Shinjiro Tomiyasu; Hiroshi Tanaka; Tetsumasa Arita; Yasushi Yagi; Hideo Baba
Journal:  Surgery       Date:  2015-10-21       Impact factor: 3.982

3.  The Therapeutic Survival Benefit of Splenic Hilar Nodal Dissection for Advanced Proximal Gastric Cancer Invading the Greater Curvature.

Authors:  Masahiro Yura; Takaki Yoshikawa; Sho Otsuki; Yukinori Yamagata; Shinji Morita; Hitoshi Katai; Toshirou Nishida
Journal:  Ann Surg Oncol       Date:  2018-12-19       Impact factor: 5.344

4.  Clinical impact of splenic hilar dissection with splenectomy for gastric stump cancer.

Authors:  Masahiro Watanabe; Takahiro Kinoshita; Shinji Morita; Masahiro Yura; Masanori Tokunaga; Sho Otsuki; Yukinori Yamagata; Akio Kaito; Takaki Yoshikawa; Hitoshi Katai
Journal:  Eur J Surg Oncol       Date:  2019-03-26       Impact factor: 4.424

5.  Risk factors for complications during surgical treatment of remnant gastric cancer.

Authors:  In Gyu Kwon; In Cho; Yoon Young Choi; Woo Jin Hyung; Choong Bai Kim; Sung Hoon Noh
Journal:  Gastric Cancer       Date:  2014-04-05       Impact factor: 7.370

6.  A Scoring System to Stratify Curability after Endoscopic Submucosal Dissection for Early Gastric Cancer: "eCura system".

Authors:  Waku Hatta; Takuji Gotoda; Tsuneo Oyama; Noboru Kawata; Akiko Takahashi; Yoshikazu Yoshifuku; Shu Hoteya; Masahiro Nakagawa; Masaaki Hirano; Mitsuru Esaki; Mitsuru Matsuda; Ken Ohnita; Kohei Yamanouchi; Motoyuki Yoshida; Osamu Dohi; Jun Takada; Keiko Tanaka; Shinya Yamada; Tsuyotoshi Tsuji; Hirotaka Ito; Yoshiaki Hayashi; Naoki Nakaya; Tomohiro Nakamura; Tooru Shimosegawa
Journal:  Am J Gastroenterol       Date:  2017-04-11       Impact factor: 10.864

7.  Priority of lymph node dissection for proximal gastric cancer invading the greater curvature.

Authors:  Yukio Maezawa; Toru Aoyama; Takanobu Yamada; Kazuki Kano; Tsutomu Hayashi; Tsutomu Sato; Takashi Oshima; Yasushi Rino; Munetaka Masuda; Takashi Ogata; Haruhiko Cho; Takaki Yoshikawa
Journal:  Gastric Cancer       Date:  2017-11-08       Impact factor: 7.370

8.  Surgical treatment of non-early gastric remnant carcinoma developing after distal gastrectomy for gastric cancer.

Authors:  Masaki Ohashi; Shinji Morita; Takeo Fukagawa; Ryoji Kushima; Hitoshi Katai
Journal:  J Surg Oncol       Date:  2014-08-30       Impact factor: 3.454

9.  Gastric remnant carcinoma after partial gastrectomy for benign and malignant gastric lesions.

Authors:  Y Kodera; Y Yamamura; A Torii; K Uesaka; T Hirai; K Yasui; T Morimoto; T Kato; T Kito
Journal:  J Am Coll Surg       Date:  1996-01       Impact factor: 6.113

10.  Clinicopathological features and surgical outcomes of patients with remnant gastric cancer after a distal gastrectomy.

Authors:  Hye Seong Ahn; Jong Won Kim; Moon-Won Yoo; Do Joong Park; Hyuk-Joon Lee; Kuhn Uk Lee; Han-Kwang Yang
Journal:  Ann Surg Oncol       Date:  2008-04-01       Impact factor: 5.344

View more
  1 in total

1.  Safety and feasibility of laparoscopic gastrectomy for remnant gastric cancer compared with open gastrectomy: Single-center experience.

Authors:  Junya Kitadani; Toshiyasu Ojima; Masaki Nakamura; Keiji Hayata; Masahiro Katsuda; Akihiro Takeuchi; Shinta Tominaga; Naoki Fukuda; Hideki Motobayashi; Tomoki Nakai; Hiroki Yamaue
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.